GSK reveals job plan to swap India for Scotland Glaxo chief explains move to Scotland
DRUGS giant GlaxoSmithKline is transferring manufacturing processes from India to Scotland and also planning to invest "tens of millions" at its operation in Ayrshire.
DRUGS giant GlaxoSmithKline is transferring manufacturing processes from India to Scotland and also planning to invest \"tens of millions\" at its operation in Ayrshire.
progress: Glaxo chief executive Andrew Witty revealed plans for the company's site in Montrose.
Custom byline text:
mark smith deputy business editor
Chief executive Andrew Witty, the plain-speaking Yorkshireman who leads the world’s third largest drugs company, said the apparently counter-intuitive move would see 1.5 tonnes of biomanufacturing to move from India to Montrose in Angus.
We moderate all comments on HeraldScotland on either a pre-moderated or post-moderated basis. If you're a relatively new user then your comments will be reviewed before publication and if we know you well then your comments will be subject to moderation only if other users or the moderators believe you've broken the rules, which are available here.
Moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours. Please be patient if your posts are not approved instantly.